News & Events
-
October 9, 2017
Critical Path Innovation Meeting
On September 14, 2017, Critical Path Institute’s (C-Path) Patient-Reported Outcome (PRO) Consortium and Electronic Patient-Reported Outcome (ePRO) Consortium participated in a Critical Path Innovation Meeting (CPIM) at the U.S Food and Drug Administration’s (FDA) White Oak campus in Silver Spring, MD. As stated on FDA’s website, the goals for CPIMs are “to discuss a methodology... - October 1, 2017
-
October 1, 2017
Enrollment of Neonates in More Than One Clinical Trial
Davis JM, Baer GR, Portman R, Nelson R, Storari L, Aranda JV, Bax R, Zajicek A, Klein A, Turner M, Baygani S, Thomson M, Allegaert K, International Neonatal Consortium. Enrollment of Neonates in More Than One Clinical Trial. Clinical Therapeutics. 2017 Oct;39(10):1959–69.
-
September 26, 2017
Coalition Against Major Diseases 2017 Annual Meeting and Regulatory Science Workshop
September 26, 2017 Overview and Objectives: The Coalition Against Major Diseases (CAMD) is a public-private partnership aimed at developing creating Drug Development Tools that can be applied to increase the efficiency of the development process of new treatments for Alzheimer disease (AD) and related dementias. The annual meeting, which is open to the public, brings... -
September 23, 2017
Seeking a Better Landscape for Therapy Development in Neuromuscular Disorders
Larkindale J, Porter JD. Seeking a Better Landscape for Therapy Development in Neuromuscular Disorders. Issues & Opinions: Improved Data Sharing for NMDs. Muscle & Nerve. 2017 Sep 23.
